XML 84 R64.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Equity (Details) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 03, 2019
Oct. 26, 2020
Dec. 31, 2021
Dec. 31, 2020
Shareholders' Equity (Details) [Line Items]        
Description of share-based compensation expenses Pursuant to the Plan (and further increase of option pool approved by the Board), 8,041,936 ordinary shares of NIS 0.01 par value of the Company are reserved for issuance upon the exercise of the same amount of awards to be granted to some of the Company’s employees, directors and consultants.      
Ordinary shares     1,841,838  
Awards were exercised on a cashless     404,704 1,027,151
Employees, officers awards to purchase     1,418,665  
Average exercise price per share (in Dollars per share)     $ 27.57  
Vesting period     4 years  
Awards agreement term     10 years  
Agreement terminate term     4 years  
Granted employees shares     180,319 1,327,957
Plus VAT (in Dollars)     $ 400,000  
Purchase aggregate shares   650,000    
Exercise price per share (in Dollars per share)   $ 18    
Recorded expense (in Dollars)     $ 6.1  
RSUs [Member]        
Shareholders' Equity (Details) [Line Items]        
Granted employees shares     47,793  
Consideration for services shares     3,221